2 - 5 | 27.4 | 18.7 | 78.6 | 42.9 | 10.0 | 0.0 |
|
|
>5 | 12.0 | 10.7 | 50.0 | 11.1 | 0.0 | 0.0 | ||
Lymph node involvement |
|
|
|
|
|
| ||
Negative | 34.5 | 31.3 | 75.0 | 68.8 | 18.8 | 0.0 | 3.114 | 0.078 |
Positive | 22.6 | 16.1 | 70.9 | 31.4 | 5.8 | 0.0 | ||
Number of lymph nodes |
|
|
|
|
|
|
| |
≤3 | 32.9 | 29.9 | 82.1 | 60.7 | 14.3 | 0.0 | 5.046* | 0.025* |
≥4 | 21.3 | 15.3 | 67.6 | 28.4 | 5.4 | 0.0 | ||
HER-2 status |
|
|
|
|
|
|
|
|
Negative | 26.2 | 18.4 | 70.1 | 41.8 | 8.9 | 0.0 | 2.365 | 0.124 |
Positive | 20.2 | 14.5 | 72.7 | 27.3 | 3.3 | 0.0 | ||
Hormone receptors status |
|
|
|
|
|
| ||
ER/PR negative | 17.4 | 12.8 | 65.0 | 20.0 | 5.0 | 0.0 | 3.833* | 0.049* |
ER/PR positive | 26.3 | 18.7 | 72.8 | 42.0 | 8.6 | 0.0 | ||
Lymph vascular invasion |
|
|
|
|
| |||
Negative | 15.6 | 11.7 | 46.2 | 23.1 | 7.6 | 0.0 | 0.133 | 0.715 |
Positive | 19.6 | 15.8 | 69.4 | 25.8 | 0.0 | 0.0 |